Taurine chloramine attenuates the hydrolytic activity of matrix metalloproteinase-9 in LPS-activated murine peritoneal macrophages.
Park
E
E
Department of Immunology, NYS Institute for Basic Research in Developmental Disabilities, Staten Island 10314, USA.
Quinn
M R
MR
Schuller-Levis
G
G
D000818:Animals; D002478:Cells, Cultured; D004492:Edetic Acid / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D006868:Hydrolysis; D018836:Inflammation Mediators / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008262:Macrophage Activation; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000201:enzymology*; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D008934:Mitogens / Q000494:pharmacology; D009573:Nitrites / Q000378:metabolism; D013654:Taurine / Q000031:analogs & derivatives / Q000494:pharmacology*
D004791:Enzyme Inhibitors; D018836:Inflammation Mediators; D008070:Lipopolysaccharides; D008934:Mitogens; D009573:Nitrites; D013654:Taurine; C043410:N-chlorotaurine; D004492:Edetic Acid; D020780:Matrix Metalloproteinase 9